Literature DB >> 15718122

Survival analytical techniques were used to assess agreement of a quantitative variable.

Javier Llorca1, Miguel Delgado-Rodríguez.   

Abstract

BACKGROUND AND
OBJECTIVE: Survival-agreement plots have been suggested as a new graphical approach to assess agreement in quantitative variables. We propose that survival analytical techniques can complement this method, providing a new analytical insight for agreement.
METHODS: Two survival-agreement plots are used to detect the bias between to measurements of the same variable. The presence of bias is tested with log-rank test, and its magnitude with Cox regression.
RESULTS: An example on C-reactive protein determinations shows how survival analytical methods would be interpreted in the context of assessing agreement.
CONCLUSION: Log-rank test, Cox regression, or other analytical methods could be used to assess agreement in quantitative variables; correct interpretations require good clinical sense.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718122     DOI: 10.1016/j.jclinepi.2004.10.011

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  3 in total

1.  Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction.

Authors:  Eduardo Marinho Tassi; Marcelo Abramoff Continentino; Emília Matos do Nascimento; Basílio de Bragança Pereira; Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2014-05-09       Impact factor: 2.000

2.  Validation of self-reported anthropometrics in the Adventist Health Study 2.

Authors:  Maira Bes-Rastrollo; Joan Sabaté; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  BMC Public Health       Date:  2011-04-05       Impact factor: 3.295

3.  Validation of self reported diagnosis of hypertension in a cohort of university graduates in Spain.

Authors:  Alvaro Alonso; Juan José Beunza; Miguel Delgado-Rodríguez; Miguel Angel Martínez-González
Journal:  BMC Public Health       Date:  2005-09-12       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.